Abstract
Background and Objectives: Until 25 July 2022, Australians who had spent more than 6 months in the United Kingdom or territories between 1980 and 1996 were deferred from blood donation due to the risk of variant Creutzfeldt-Jakob disease. Removal of this geography-based donor deferral on RhD-negative blood availability has not been reported. Materials and Methods: All donors who donated at least once from 25 July 2022 to 25 July 2023 were included. UK donor status, first-time donor and ABO RhD data were extracted from the National Blood Management System. Results: Data from 566,447 blood donors with a valid ABO RhD result were analysed. Of these, 34,560 were new or returning lapsed donors following removal of the UK donor deferral. The median age [range] in years for all donors was 43 [75] with UK donors being older 53 [70]. There was a higher prevalence of RhD-negative status in UK donors (20.2%) compared with first-time blood donors (15.7%). Conclusion: UK donors were generally older, female and more likely to be RhD-negative. Although UK donors provided a boost to RhD-negative blood collections, the overall prevalence of ABO RhD blood groups in the total Australian blood donor panel remained similar to previous estimates.
| Original language | English |
|---|---|
| Pages (from-to) | 619-623 |
| Number of pages | 5 |
| Journal | Vox Sanguinis |
| Volume | 119 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - Jun 2024 |
Open Access - Access Right Statement
This is an open access article under the terms of the Creative Commons AttributionLicense [https://creativecommons.org/licenses/by/4.0/]UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- blood groups
- blood donor
- UK
- blood donation deferral
- variant Creutzfeldt–Jakob disease
- Australia
Fingerprint
Dive into the research topics of 'Has the frequency of ABO RhD blood groups in Australian blood donors changed as a result of the removal of the variant Creutzfeldt-Jakob disease-based deferral?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver